Pharmacy Times

JUNE 23, 2025

The presentation emphasized early intervention and personalized treatment plans in managing type 2 diabetes, shifting from "treating to failure" to "treating to target." He was joined by Laura, a patient who began tirzepatide treatment shortly after being diagnosed with T2D.

Diabetes 32

Diabetes HIV Treatment and Prevention Agents Pharmacy Technician Compounding Pharmacies 32

ID Stewardship

JUNE 19, 2025

AI-Generated Summary This article by infectious diseases pharmacist Aneeka Chavda outlines five key considerations for pharmacists in the treatment of Mycobacterium tuberculosis (TB), particularly drug-sensitive cases. The piece advocates for therapeutic drug monitoring (TDM) in specific high-risk groups to personalize treatment.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Adverse Reactions Dosage Labelling 52

Pharmacy Times

JULY 1, 2025

SHOW MORE Pharmacists can help oversee the treatment process to ensure patients with transthyretin amyloid cardiomyopathy (ATTR-CM) are adhering to tafamidis. Tafamidis offers a targeted approach by directly addressing the protein’s instability, whereas other treatments address upstream causes.

HIV Treatment and Prevention Agents 35

HIV Treatment and Prevention Agents Pharmacy Technician Insurance Coverage and Processing Specialty Pharmacies 35

ID Stewardship

DECEMBER 11, 2024

I wonder if this will cause us to be more fragmented as a group in 2025 and if Bluesky will really have sticking power. Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women | NEJM PURPOSE 1 RCT : No participants receiving twice-yearly lenacapavir acquired HIV infection. Mastodon sure did not.

HIV Treatment and Prevention Agents 145

HIV Treatment and Prevention Agents Labelling Hospitals Communication 145